Can You Take Tongkat Ali and Fadogia Agrestis Together?

No clinical trial has ever tested Tongkat Ali and Fadogia Agrestis taken together in humans. The two supplements are frequently “stacked” in the fitness and testosterone-optimization community, but the safety and efficacy of the combination is entirely uncharted. Tongkat Ali has a modest body of human research behind it; Fadogia Agrestis has essentially none, with its reputation resting on a pair of rat studies from the mid-2000s. That asymmetry matters more than most supplement marketing acknowledges.

What the Human Evidence Says About Tongkat Ali

Tongkat Ali (Eurycoma longifolia) is the better-studied half of this pairing by a wide margin. A systematic review and meta-analysis of clinical trials found a statistically significant increase in total testosterone levels in men receiving Tongkat Ali supplementation, with the effect confirmed in a subgroup of men with low testosterone.¹ A six-month randomized controlled trial in men with age-related testosterone decline found that Tongkat Ali combined with exercise improved both erectile function and total testosterone compared to exercise alone.² In moderately stressed subjects, four weeks of supplementation was associated with a roughly 37% increase in testosterone status alongside a 16% reduction in cortisol.³

A pilot study in physically active older adults reported significant increases in both total and free testosterone in men and women. In women, the rise in free testosterone appeared to be driven by a decline in sex hormone-binding globulin, the protein that locks testosterone into an inactive form.⁴ These results are encouraging, but the trials are still small, and the effect is most reliably observed in people whose testosterone was already compromised by age, stress, or clinical hypogonadism. A study in healthy young males found that testosterone and free testosterone did rise, but luteinising hormone and follicle-stimulating hormone did not change, suggesting the mechanism in younger men may work differently than in older ones.⁵

The Fadogia Problem

Fadogia Agrestis is the weak link in this stack, and it is important to be honest about how weak the evidence is. The entire scientific case for Fadogia’s testosterone-boosting properties rests on two studies, both conducted in rats, both from the same research group, and both published in 2005 and 2007. The first found that an aqueous extract of Fadogia stem increased blood testosterone concentrations in male albino rats.⁶ The second reported changes in testicular markers after 28 days of oral extract administration, including shifts in enzyme activity and testicular cholesterol.⁷

That second study is actually the one that should give you pause. Alongside the testosterone-related changes, researchers observed significant alterations in testicular function markers, including decreases in testicular protein concentration and shifts in enzyme activities that can indicate tissue stress. These are not reassuring findings, even in an animal model. And no human trial of Fadogia Agrestis has been published in the roughly two decades since those papers appeared. The supplement became wildly popular after being mentioned on a high-profile podcast, not because new evidence emerged. When you hear someone say Fadogia “raises testosterone,” they are extrapolating from two small rat studies to a conclusion about human physiology. That is a larger leap than it sounds.

Why People Stack Them

The theoretical logic behind combining the two is that they might boost testosterone through different pathways. Tongkat Ali is thought to act partly through the hypothalamic-pituitary-adrenal axis, reducing cortisol and creating a hormonal environment more favorable to testosterone production.³ In young men, it may increase testosterone production rate without meaningfully changing the signaling hormones upstream, which suggests its effects may occur further downstream in the hormone chain.⁵ Fadogia, based on the animal data, is proposed to act more directly on testicular tissue itself, potentially stimulating testosterone synthesis at the gland level.

The idea is that if one supplement works at the brain-hormone level and the other at the testicular level, stacking them would produce a bigger overall effect. In pharmacology, this kind of reasoning can sometimes pan out. But “sometimes pans out in pharmacology” and “has been demonstrated for these two specific supplements in humans” are very different statements. Nobody has tested whether the mechanisms are actually complementary, whether they interfere with each other, or whether the combination introduces risks that neither ingredient carries alone. The stacking rationale exists entirely in the realm of biological plausibility, not evidence.

Safety Concerns Worth Taking Seriously

The absence of human data on Fadogia is not just an evidence gap for efficacy. It is a safety gap. When a compound has only been tested in rats, you do not know its dose-response curve in humans, its interactions with liver enzymes, or what happens when someone takes it daily for months. The second rat study already hinted at testicular tissue changes at standard doses, and the study only ran 28 days.⁷ What happens over six months of daily use in a human is genuinely unknown.

Liver injury is one concrete risk to consider. Herbal and dietary supplements are a recognized cause of liver damage, and multi-ingredient supplements are particularly problematic. A review of drug-induced liver injury cases found that the majority of non-anabolic-steroid supplement cases (about two-thirds) were attributed to multi-ingredient nutritional supplements rather than single named herbs.⁸ A case report in a military medicine journal documented liver injury associated with a testosterone booster product that contained Eurycoma longifolia (Tongkat Ali) alongside ashwagandha and ginseng, noting that liver injury from that particular product line had been reported before.⁹ Whether the Tongkat Ali itself was the culprit, or the combination with other ingredients, or a contaminant in the manufacturing process is exactly the kind of question that remains unanswered for most supplement stacks.

A case report on testosterone booster products more broadly noted that even products obtained from trusted sources may negatively affect hepatic function.¹⁰ Over-the-counter herbal supplements marketed for testosterone remain poorly studied, and a review on non-testosterone management of male hypogonadism flagged the potential for abuse as well as increased liver and cardiovascular risks with such products.¹¹ Adding Fadogia, which has zero published human safety data, to a Tongkat Ali regimen means stacking an understudied ingredient on top of one that already carries some hepatic caution flags.

Adulteration and What Is Actually in the Bottle

Beyond the question of whether these ingredients work is the question of whether the product you buy actually contains what the label claims. Adulteration and contamination in the supplement industry are not theoretical concerns. A review of male enhancement nutraceuticals found that the global market is flooded with counterfeit and adulterated products, many mislabeled as natural but actually spiked with pharmaceutical ingredients.¹² A toxicological screening of herbal supplements found that nearly half of products tested had contamination issues, including undeclared stimulants like caffeine and ephedrine, pharmaceutical drugs, and animal ingredients not listed on the label.¹³

Fadogia Agrestis is especially vulnerable to these problems. It is a relatively obscure West African shrub that rocketed into commercial demand before a reliable global supply chain existed. When demand for a plant extract surges faster than sourcing can scale, the incentives for substitution, dilution, or outright faking become very strong. There is no widely recognized standardization marker for Fadogia the way eurycomanone serves as a quality marker for Tongkat Ali. You may be buying ground-up stem of the right plant, a different plant entirely, or a mix with undeclared fillers. This is not speculation; it is the predictable outcome of an unregulated supply chain facing sudden consumer demand.

For Tongkat Ali, the picture is somewhat better. Standardized water extracts have been characterized in pharmacokinetic studies, and eurycomanone (the primary bioactive compound) can be measured and verified.¹⁴ Look for products that specify their eurycomanone content or use patented standardized extracts. Even then, Tongkat Ali’s key compound has poor oral bioavailability; rodent studies measured it at roughly 10–11% in rats, with the compound not easily absorbed across biological membranes despite being stable once it reaches the bloodstream.¹⁵ This does not mean the supplement cannot work, but it does mean that the bioactive compound has a harder time getting into your system than many people assume.

What Blood Work Can and Cannot Tell You

If you decide to take either or both of these supplements, periodic blood testing is one of the few tools available to judge whether anything useful is happening and whether anything harmful is starting. At minimum, a baseline panel of total testosterone, free testosterone, and liver enzymes before you begin gives you something to compare against. A follow-up panel after six to eight weeks of consistent use can show you whether your testosterone actually changed and whether your liver markers have shifted.

The reality, though, is that testosterone fluctuates substantially throughout the day and in response to sleep, stress, training, and diet. A single blood draw can be misleading. If your post-supplement testosterone is higher than your pre-supplement reading, the supplement might deserve credit, or you might have slept better the night before. This is why controlled trials with proper sample sizes matter, and why individual blood work, while better than nothing, is not the same as evidence. Monitoring for liver and kidney safety is more straightforward: if your ALT, AST, or other hepatic markers start climbing after introducing a new supplement, that is a signal worth acting on, regardless of what your testosterone numbers look like. Clinical guidance for testosterone replacement therapy emphasizes that screening and ongoing monitoring are necessary to ensure both efficacy and safety.¹⁶ The same principle applies when using supplements that claim to influence the same hormonal system.

Does the Combination Actually Build More Muscle?

Most people interested in this stack ultimately want to know whether it translates into tangible performance or body composition results. Even with Tongkat Ali alone, the exercise performance data is mixed. One eight-week trial combining Tongkat Ali supplementation with resistance training in young males found some improvements in knee flexion power and anaerobic peak power, but the supplement-plus-training group did not consistently outperform the training-only group on all measures.¹⁷ Another trial in rugby players found that seven days of Tongkat Ali supplementation before an eccentric leg press session had no significant effect on hormones, performance recovery, or muscle damage markers.¹⁸

This is worth sitting with. Even the supplement with real human data behind its testosterone effects does not reliably produce measurable gains in strength or muscle recovery in controlled settings, at least in the trials published so far. The magnitude of testosterone increase seen with Tongkat Ali, while statistically significant, is modest compared to pharmaceutical testosterone replacement. If Tongkat Ali alone produces inconsistent performance benefits, it is hard to make a confident case that adding Fadogia, which has never been shown to do anything in humans, will push you over a meaningful threshold.

Women and Tongkat Ali

While the Tongkat Ali and Fadogia stack is mostly discussed in male fitness spaces, Tongkat Ali alone has been explored in women. The pilot study mentioned earlier found significant increases in free testosterone in physically active older women, linked to a drop in sex hormone-binding globulin.⁴ A randomized trial protocol has been published to evaluate a standardized Tongkat Ali extract in perimenopausal and postmenopausal women, looking at quality-of-life measures over 12 weeks.¹⁹ Results from that trial have not yet been published, so we do not know whether the benefits seen in the small pilot study will hold up in a larger, more rigorous design. For women considering the Tongkat Ali and Fadogia stack specifically, there is even less reason to include Fadogia. The animal studies were conducted in male rats, and no data of any kind exists on Fadogia in female biology, human or otherwise.

Cycling and Dosing Conventions

You will find cycling protocols all over supplement forums: “four weeks on, one week off” or “eight weeks on, two weeks off.” These schedules are not derived from clinical evidence. Most of the human trials on Tongkat Ali used continuous daily dosing for anywhere from four weeks to six months, with no cycling breaks built into the study design. The cycling advice comes from bodybuilding culture’s experience with stronger hormonal compounds, where breaks serve to prevent receptor desensitization or suppress side effects. Whether the same logic applies to an herbal extract with modest hormonal effects is unknown.

Typical Tongkat Ali doses in published studies range from 200 mg to 600 mg daily of a standardized water extract. Fadogia doses in the rat studies were expressed in milligrams per kilogram of body weight, and translating animal doses to human-equivalent doses is not as simple as multiplying by body weight. The 600 mg per day dose commonly sold for Fadogia in human supplements does not come from a clinical trial. It comes from rough allometric scaling of the rat data, plus marketing judgment about what consumers will tolerate. There is no human dose-finding study to confirm whether 600 mg is effective, safe, too low, or too high.